Clinical Trials Logo

Pharmacokinetics of Anatabine clinical trials

View clinical trials related to Pharmacokinetics of Anatabine.

Filter by:
  • None
  • Page 1

NCT ID: NCT02432313 Completed - Clinical trials for Pharmacokinetics of Anatabine

Safety, Tolerability, and Pharmacokinetics of Modified and Immediate Release Anatabine Citrate Formulations

Start date: January 2015
Phase: Phase 1
Study type: Interventional

Parts 1 and 2: Subjects take 1 dose of various formulations of the study product, and provide samples for pharmacokinetic (PK) analysis after each, with at least 7 days between doses. Part 3: Subjects take 2-4 doses of study product or placebo for 6 days, plus 1 additional dose, and provides samples for PK analysis.